Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nina Orfali, Yuliya Jhanwar, Calvin Koo, Michelle Pasciolla, Maria Baldo, Edwidge Cuvilly, Richard Furman, Usama Gergis, June Greenberg, Danielle Guarneri, Jing-Mei Hsu, John P. Leonard, Tomer Mark, Sebastian Mayer, Kathleen Maignan, Peter Martin, Adomah Opong, Roger Pearse, Adrienne Phillips, Adriana Rossi, Jia Ruan, Sarah C. Rutherford, Jessy Ryan, Grace Suhu, Koen Van Besien & Tsiporah Shore. (2021) Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma. Leukemia & Lymphoma 62:7, pages 1629-1638.
Read now
Read now
Byeong-Bae Park, Won Seog Kim, Cheolwon Suh, Jung Yong Hong, Deok-Hwan Yang, Won Sik Lee, Young Rok Do, Young Il Koh, Jong-Ho Won, Min Kyoung Kim, Jae-Cheol Jo, Shin Young Hyun, Jeong-A Kim, Young Ha Oh & Seung-Sook Lee. (2019) A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial). Leukemia & Lymphoma 60:13, pages 3251-3257.
Read now
Read now
Ferenc Magyari, Sándor Barna, Kata Husi, Zsófia Simon, Zsófia Miltényi, László Váróczy, Miklós Udvardy & Árpád Illés. (2016) Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma. Hematology 21:7, pages 404-410.
Read now
Read now
Alessandra Tedeschi, Paola Picardi, Simone Ferrero, Giulia Benevolo, Gloria Margiotta Casaluci, Marzia Varettoni, Claudia Baratè, Marina Motta, Guido Gini, Maria Cecilia Goldaniga, Carlo Visco, Francesco Zaja, Valeria Belsito Petrizi, Erika Ravelli, Massimo Gentile, Marina Aurora Urbano, Silvia Franceschetti, Paola Ghione, Lorella Orsucci, Anna Maria Frustaci, Gianluca Gaidano, Umberto Vitolo & Enrica Morra. (2015) Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia. Leukemia & Lymphoma 56:9, pages 2637-2642.
Read now
Read now
Articles from other publishers (10)
Masuho SaburiKazuki OkuhiroNatsumi YoshidaTakami HaruyamaYui MorogaYuka YanaiKazuhito ItaniKuniko TakanoShuhei HondaKeiji OnoManami Iwanaga, Hitohiro Sasaki, Miyuki Abe, Kazuhiro Kohno, Toshiyuki Nakayama, Eiichi OhtsukaMasao Ogata. (2023) Infections associated with bendamustine and anti-CD20 antibody in untreated follicular lymphoma: a real-world study. Journal of Clinical and Experimental Hematopathology.
Crossref
Crossref
Lina Yao, Zhenzhong Zuo, Ziyi Gong, Dan Sun, Xiaoqiang Feng & Kaige Wang. (2022) Interaction between anticancer drug bendamustine and calf thymus DNA with spectroscopy at the single-molecule level. Interaction between anticancer drug bendamustine and calf thymus DNA with spectroscopy at the single-molecule level.
Yuyang Gao, Xiaoyan Feng, Wenting Song, Hongwen Li, Cunzhen Shi, Mengyuan Jin, Zhaoming Li, Lei Zhang & Mingzhi Zhang. (2022) The potential efficacy and mechanism of bendamustine in entra‐nodal NK/T cell lymphoma. Hematological Oncology 40:4, pages 678-688.
Crossref
Crossref
Rebecca E. Tanenbaum, Anat Galor, Sander R. Dubovy & Carol L. Karp. (2019) Classification, diagnosis, and management of conjunctival lymphoma. Eye and Vision 6:1.
Crossref
Crossref
David Ribes, Hélène E. L. Hachem, Lucie Oberic, François Vergez, Audrey Delas, Julie Belliere, Caroline Protin, Nassim Kamar, Inès Ferrandiz, Suzanne Tavitian, Camille Laurent, Antoine Huart, Dominique Chauveau, Loïc Ysebaert & Stanislas Faguer. (2018) Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance. American Journal of Hematology 93:3, pages 356-362.
Crossref
Crossref
Emilie Reboursiere, Fabien Le Bras, Charles Herbaux, Emmanuel Gyan, Aline Clavert, Franck Morschhauser, Sandra Malak, David Sibon, Florence Broussais, Thorsten Braun, Luc-Matthieu Fornecker, Reda Garidi, Sabine Tricot, Roch Houot, Bertrand Joly, Wajed Abarah, Bachra Choufi, Anne-Dominique Pham, Anne-Claire Gac, Christophe Fruchart, Emilie Marin, Violaine Safar, Anne Parcelier, Hervé Maisonneuve, Emmanuel Bachy, Guillaume Cartron, Arnaud Jaccard, Olivier Tournilhac, Cédric Rossi, Luciane Schirmer, Jean-Alain Martignoles, Philippe Gaulard, Hervé Tilly, Gandhi Damaj & From the Lymphoma Study Association centers. (2016) Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study. Oncotarget 7:51.
Crossref
Crossref
Alexandra Albertsson-LindbladArne Kolstad, Anna LaurellRiikka RätyKirsten GrønbækJan SundbergLone Bredo PedersenElisabeth RalfkiærMarja-Liisa Karjalainen-LindsbergChrister Sundström, Mats Ehinger, Christian GeislerMats Jerkeman. (2016) Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma. Blood 128:14, pages 1814-1820.
Crossref
Crossref
Jessica Stokes, Emely A. Hoffman, Yi Zeng, Nicolas Larmonier & Emmanuel Katsanis. (2016) Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation. British Journal of Haematology 174:1, pages 102-116.
Crossref
Crossref
Benjamin Izar, David P. Ryan & Bruce A. Chabner. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology
171
185.e2
.
Marielle Perry, Antoine Delarche, David Ribes, François Vergez, Céline Guilbeau-Frugier, Camille Laurent, Antoine Huart, Suzanne Tavitian, Hélène El Hachem, Lucie Oberic, Dominique Chauveau, Anne-Sophie Michallet, Loïc Ysebaert & Stanislas Faguer. (2014) Rituximab-cyclophosphamide-dexamethasone is highly effective in patients with monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomas. American Journal of Hematology 89:10, pages 969-973.
Crossref
Crossref